Senator Bernie Sanders needs to satisfy subsequent week with Novo Nordisk A/S’s prime govt about decreasing the value of its blockbuster drug Ozempic, fueling controversy over the prices of GLP-1 medication for diabetes and weight problems.The Vermont unbiased stated he’s contemplating hearings on the price of GLP-1 medication like Ozempic, however first needs to personally talk about their costs with Novo Chief Government Officer Lars Fruergaard Jørgensen.